LBA33 Maintenance olaparib rechallenge in patients (pts) with ovarian carcinoma (OC) previously treated with a PARP inhibitor (PARPi): Phase IIIb OReO/ENGOT Ov-38 trial

Éric Pujade-Lauraine, Frédèric Selle, Giovanni Scambia, Bernard Asselain, Frederik Marmé, Kristina Lindemann, Nicoletta Colombo, Radosław Mądry, Rosalind Glasspool, Coraline Dubot, Ana Oaknin, Claudio Zamagni, Florian Heitz, Laurence Gladieff, María Jesús Rubio-Pérez, Paolo Scollo, Christopher Blakeley, Brian Shaw, Isabelle Laure Ray-Coquard, Andrés Redondo